{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:54Z","timestamp":1793294034013,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371086"],"award-info":[{"award-number":["82371086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171084"],"award-info":[{"award-number":["82171084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.dsx.2023.102882","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T01:46:00Z","timestamp":1698025560000},"page":"102882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Serum cystatin C for risk stratification of prediabetes and diabetes populations"],"prefix":"10.1016","volume":"17","author":[{"given":"Kun","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5273-3332","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2023.102882_bib1","series-title":"IDF diabetes Atlas IDF","year":"2021"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12916-019-1355-0","article-title":"Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants","volume":"17","author":"Wang","year":"2019","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.dsx.2023.102882_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.dsx.2023.102882_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00125-019-4928-8","article-title":"Does diabetes prevention translate into reduced long-term vascular complications of diabetes?","volume":"62","author":"Nathan","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.dsx.2023.102882_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2337\/dc11-1998","article-title":"Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes","volume":"35","author":"Sch\u00f6ttker","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2023.102882_bib7","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/dc13-1910","article-title":"Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S","volume":"37","author":"Tsai","year":"2014","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.dsx.2023.102882_bib8","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/dc11-2220","article-title":"Serum concentration of cystatin C and risk of end-stage renal disease in diabetes","volume":"35","author":"Krolewski","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2023.102882_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4093\/dmj.2018.0006","article-title":"Association between serum cystatin C and vascular complications in type 2 diabetes mellitus without nephropathy","volume":"42","author":"Kim","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-016-0470-x","article-title":"Impact of diabetes on the predictive value of heart failure biomarkers","volume":"15","author":"Alonso","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1016\/j.dsx.2023.102882_bib11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc07-0040","article-title":"Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study","volume":"30","author":"Donahue","year":"2007","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2023.102882_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10654-013-9781-3","article-title":"Serum cystatin C and prediabetes in non-obese US adults","volume":"28","author":"Sabanayagam","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.dsx.2023.102882_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.13220","article-title":"Analysis of plasma metabolic profile on ganglion cell-inner plexiform layer thickness with mortality and common diseases","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12916-023-02728-7","article-title":"Retinal nerve fiber layer thinning as a novel fingerprint for cardiovascular events: results from the prospective cohorts in UK and China","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.dsx.2023.102882_bib15","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/STROKEAHA.113.004629","article-title":"Localized retinal nerve fiber layer defects and stroke","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.dsx.2023.102882_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0271678X221135658","article-title":"Retinal capillary microvessel morphology changes are associated with vascular damage and dysfunction in cerebral small vessel disease","volume":"43","author":"Wiseman","year":"2023","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"Pt 7","key":"10.1016\/j.dsx.2023.102882_bib17","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/brain\/awq127","article-title":"Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study","volume":"133","author":"Cheung","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.dsx.2023.102882_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2023.102882_bib19","first-page":"S15","article-title":"Classification and diagnosis of diabetes: standards of medical Care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2023.102882_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.dsx.2023.102882_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.12.5.8","article-title":"Correlation between coronary and retinal microangiopathy in patients with STEMI","volume":"12","author":"Sideri","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.dsx.2023.102882_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/02713683.2023.2182745","article-title":"Design and baseline data of the diabetes registration study: Guangzhou Diabetic Eye Study","volume":"48","author":"Zhang","year":"2023","journal-title":"Curr Eye Res"},{"issue":"10","key":"10.1016\/j.dsx.2023.102882_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9833","key":"10.1016\/j.dsx.2023.102882_bib24","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2023.102882_bib25","doi-asserted-by":"crossref","first-page":"m2297","DOI":"10.1136\/bmj.m2297","article-title":"Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.dsx.2023.102882_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102226","article-title":"Prevalence of diabetes related vascular complications in subjects with normal glucose tolerance, prediabetes, newly detected diabetes and known diabetes","volume":"15","author":"Yadav","year":"2021","journal-title":"Diabetes Metabol Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001061","article-title":"Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes","volume":"8","author":"Palladino","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.dsx.2023.102882_bib28","doi-asserted-by":"crossref","first-page":"i6538","DOI":"10.1136\/bmj.i6538","article-title":"Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions","volume":"356","author":"Barry","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.dsx.2023.102882_bib29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","author":"Emerging Risk Factors","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.dsx.2023.102882_bib30","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1161\/STROKEAHA.122.039277","article-title":"Association of serum cystatin C with cerebral small vessel disease in community-based population","volume":"53","author":"Yao","year":"2022","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.dsx.2023.102882_bib31","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin Chem"},{"issue":"5\u20136","key":"10.1016\/j.dsx.2023.102882_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10408360490504934","article-title":"Biochemistry and clinical role of human cystatin C","volume":"41","author":"Mussap","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.dsx.2023.102882_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.0000117180.57731.36","article-title":"Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease","volume":"24","author":"Eriksson","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.dsx.2023.102882_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/2047487316637182","article-title":"Cystatin C, chronic kidney disease and retinopathy in adults without diabetes","volume":"23","author":"Ng","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.dsx.2023.102882_bib35","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/j.diabres.2008.11.032","article-title":"Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy","volume":"83","author":"Kimura","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.dsx.2023.102882_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diabres.2007.09.016","article-title":"Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy","volume":"79","author":"Ogawa","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dsx.2018.08.017","article-title":"Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus","volume":"13","author":"Elsayed","year":"2019","journal-title":"Diabetes Metabol Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2023.102882_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.11.044","article-title":"Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy","volume":"62","author":"Pavkov","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dsx.2023.102882_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1475-2840-12-157","article-title":"Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus","volume":"12","author":"Fu","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dsx.2023.102882_bib40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.maturitas.2020.10.016","article-title":"Cystatin C-based estimated GFR and albuminuria are independently associated with all-cause and CVD mortality in Korean population: the Dong-gu Study","volume":"143","author":"Kim","year":"2021","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.dsx.2023.102882_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaophthalmol.2022.1175","article-title":"Multicenter evaluation of diagnostic circulating biomarkers to detect sight-threatening diabetic retinopathy","volume":"140","author":"Gurudas","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.dsx.2023.102882_bib42","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00125-011-2257-7","article-title":"Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy","volume":"54","author":"Aspelund","year":"2011","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.dsx.2023.102882_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc11-2282","article-title":"Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?","volume":"35","author":"Chalk","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2023.102882_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:50:15Z","timestamp":1778827815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402123001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1871402123001789"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102882","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cystatin C for risk stratification of prediabetes and diabetes populations","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102882"}}